Human Genome Epidemiology Literature Finder
Records 1 - 14 (of 14 Records) |
Query Trace: Adenocarcinoma and NFE2L2[original query] |
---|
Keap1 mutations in lung cancer patients. Oncology letters 2013 Sep 6 (3): 719-721. Sasaki Hidefumi, Suzuki Ayumi, Shitara Masayuki, Okuda Katsuhiro, Hikosaka Yu, Moriyama Satoru, Yano Motoki, Fujii Yoshita |
PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort. Lung cancer (Amsterdam, Netherlands) 2017 12 112 96-101. Sawa Kenji, Koh Yasuhiro, Kawaguchi Tomoya, Kambayashi Satoshi, Asai Kazuhisa, Mitsuoka Shigeki, Kimura Tatsuo, Yoshimura Naruo, Yoshimoto Naoki, Kubo Akihito, Saka Hideo, Matsumura Akihide, Wanibuchi Hideki, Yamamoto Nobuyuki, Nishiyama Noritoshi, Hirata Kazu |
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct . Arbour Kathryn C, Jordan Emmett, Kim Hyunjae Ryan, Dienstag Jordan, Yu Helena A, Sanchez-Vega Francisco, Lito Piro, Berger Michael, Solit David B, Hellmann Matthew, Kris Mark G, Rudin Charles M, Ni Ai, Arcila Maria, Ladanyi Marc, Riely Gregory |
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 7 14 (11): 1924-1934. Goeman Frauke, De Nicola Francesca, Scalera Stefano, Sperati Francesca, Gallo Enzo, Ciuffreda Ludovica, Pallocca Matteo, Pizzuti Laura, Krasniqi Eriseld, Barchiesi Giacomo, Vici Patrizia, Barba Maddalena, Buglioni Simonetta, Casini Beatrice, Visca Paolo, Pescarmona Edoardo, Mazzotta Marco, De Maria Ruggero, Fanciulli Maurizio, Ciliberto Gennaro, Maugeri-Saccà Marcel |
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
Association of variations in platinum resistance-related genes and prognosis in lung cancer patients. Journal of Cancer 2020 6 11 (15): 4343-4351. Zhou Yuan-Kang, Li Xiang-Ping, Yin Ji-Ye, Zou Ting, Wang Zhan, Wang Ying, Cao Lei, Chen Juan, Liu Zhao-Qi |
Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients. Scientific reports 2020 Feb 10 (1): 2070. Jiang Ruirui, Zhang Bo, Teng Xiaodong, Hu Peizhen, Xu Sanpeng, Zheng Zuyu, Liu Rui, Tang Tingdong, Ye Fe |
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical lung cancer 2020 Oct . Riess Jonathan W, Frankel Paul, Shackelford David, Dunphy Mark, Badawi Ramsey D, Nardo Lorenzo, Cherry Simon R, Lanza Ian, Reid Joel, Gonsalves Wilson I, Kunos Charles, Gandara David R, Lara Primo N, Newman Edward, Paik Paul |
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis. Oxidative medicine and cellular longevity 2020 10 2020 3580719. Ju Qiang, Li Xinmei, Zhang Heng, Yan Songxia, Li Ying, Zhao Yanj |
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations. Oncotarget 2021 4 12 (6): 578-588. Joshi Asim, Mishra Rohit, Desai Sanket, Chandrani Pratik, Kore Hitesh, Sunder Roma, Hait Supriya, Iyer Prajish, Trivedi Vaishakhi, Choughule Anuradha, Noronha Vanita, Joshi Amit, Patil Vijay, Menon Nandini, Kumar Rajiv, Prabhash Kumar, Dutt Am |
Multiomics analysis of tumor mutational burden across cancer types. Computational and structural biotechnology journal 2021 19 5637-5646. Li Lin, Bai Long, Lin Huan, Dong Lin, Zhang Rumeng, Cheng Xiao, Liu Zexian, Ouyang Yi, Ding Kesh |
Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2. Journal of Cancer 2022 4 13 (5): 1512-1522. Yang Xiaodong, Li Ming, Chen Zhencong, Fan Xiaobin, Guo Liang, Jin Bo, Huang Yiwei, Wang Qun, Wu Liang, Zhan Che |
Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. Global medical genetics 2024 4 11 (2): 150-158. Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zha |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: